爱博医疗：报告期内，新增商誉系公司通过投资并购方式自主掌控境外优质品牌与成熟渠道所致

Core Viewpoint - The company, Aibo Medical, has increased its goodwill from 139 million yuan in December 2024 to 191 million yuan in the third quarter of 2025, indicating significant investments aimed at international expansion and acquisition of overseas brands and channels [2]. Group 1 - The increase in goodwill by over 50 million yuan is attributed to the company's strategic investments and acquisitions to enhance its international market presence [2]. - The company aims to independently control high-quality overseas brands and established channels through these investments [2].